• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类耳毒性的遗传易感性:有多少人面临风险?

Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?

作者信息

Tang Hsiao-Yuan, Hutcheson Eldridge, Neill Susan, Drummond-Borg Margaret, Speer Michael, Alford Raye Lynn

机构信息

The Bobby R. Alford Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

Genet Med. 2002 Sep-Oct;4(5):336-45. doi: 10.1097/00125817-200209000-00004.

DOI:10.1097/00125817-200209000-00004
PMID:12394346
Abstract

PURPOSE

To assess the occurrence of two mutations associated with susceptibility to aminoglycoside ototoxicity.

METHODS

Genetic analysis of anonymized, residual diagnostic specimens.

RESULTS

One occurrence of the A1555G mutation and seven occurrences of the 961delT + C(n) nucleotide change were found. Two previously unreported sequence changes, T961G and 956-960insC, were also found in six and five specimens, respectively.

CONCLUSIONS

Genetic susceptibility to aminoglycoside ototoxicity may be more common than previously suspected. Further study of the 961delT + C(n) mutation is recommended to confirm its role in aminoglycoside ototoxicity and assess penetrance and variability with and without exposure to aminoglycoside antibiotics.

摘要

目的

评估与氨基糖苷类耳毒性易感性相关的两种突变的发生情况。

方法

对匿名的残留诊断标本进行基因分析。

结果

发现1例A1555G突变和7例961delT + C(n)核苷酸变化。在6份和5份标本中还分别发现了两种先前未报告的序列变化,即T961G和956 - 960insC。

结论

氨基糖苷类耳毒性的遗传易感性可能比之前怀疑的更为常见。建议对961delT + C(n)突变进行进一步研究,以确认其在氨基糖苷类耳毒性中的作用,并评估在接触和未接触氨基糖苷类抗生素情况下的外显率和变异性。

相似文献

1
Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?氨基糖苷类耳毒性的遗传易感性:有多少人面临风险?
Genet Med. 2002 Sep-Oct;4(5):336-45. doi: 10.1097/00125817-200209000-00004.
2
Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications.氨基糖苷类药物耳毒性的遗传易感性:遗传异质性及临床意义。
Am J Otolaryngol. 1999 May-Jun;20(3):151-6. doi: 10.1016/s0196-0709(99)90062-5.
3
Genetic factors in aminoglycoside toxicity.
Ann N Y Acad Sci. 1999 Nov 28;884:99-109. doi: 10.1111/j.1749-6632.1999.tb08639.x.
4
[Aminoglycoside ototoxicity associated with mitochondrial DNA mutation].与线粒体DNA突变相关的氨基糖苷类耳毒性
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1999 May;13(5):195-7.
5
A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness.一种检测与氨基糖苷类药物致聋相关的五种已知突变的快速方法。
BMC Med Genet. 2009 Jan 13;10:2. doi: 10.1186/1471-2350-10-2.
6
Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity.一名散发性氨基糖苷类耳毒性患者的线粒体核糖体RNA基因突变
Am J Otolaryngol. 1993 Nov-Dec;14(6):399-403. doi: 10.1016/0196-0709(93)90113-l.
7
Genetic susceptibility to aminoglycoside ototoxicity.对氨基糖苷类耳毒性的遗传易感性。
Int J Pediatr Otorhinolaryngol. 2019 May;120:15-19. doi: 10.1016/j.ijporl.2019.02.002. Epub 2019 Feb 4.
8
Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity.
Am J Otolaryngol. 1997 May-Jun;18(3):173-8. doi: 10.1016/s0196-0709(97)90078-8.
9
[Progress in genetic susceptibility to aminoglycoside-induced deafness].[氨基糖苷类抗生素致聋遗传易感性研究进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):375-379. doi: 10.13201/j.issn.2096-7993.2021.04.021.
10
Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity.来自蒙古的两个母系遗传氨基糖苷类耳毒性家族的线粒体12S rRNA基因突变。
J Med Genet. 1997 Feb;34(2):169-72. doi: 10.1136/jmg.34.2.169.

引用本文的文献

1
The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence.与氨基糖苷类药物致聋相关的线粒体突变在拉脱维亚族群中的流行情况:证据评估。
J Hum Genet. 2019 Mar;64(3):199-206. doi: 10.1038/s10038-018-0544-6. Epub 2018 Dec 6.
2
Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity.与氨基糖苷类药物所致耳毒性相关的线粒体DNA突变
J Otol. 2017 Mar;12(1):1-8. doi: 10.1016/j.joto.2017.02.001. Epub 2017 Feb 11.
3
Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity.
炎症增强氨基糖苷类药物所致耳毒性的潜在机制
Front Cell Neurosci. 2017 Nov 21;11:362. doi: 10.3389/fncel.2017.00362. eCollection 2017.
4
Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.应用美国成人患者耳毒性监测国家指南:关于患者群体、服务差距、障碍及解决方案的观点
Int J Audiol. 2018 Sep;57(sup4):S3-S18. doi: 10.1080/14992027.2017.1398421. Epub 2017 Nov 20.
5
Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach.使用基于微阵列的方法筛查在欧洲血统患者中常见的致聋DNA变异。
PLoS One. 2017 Mar 8;12(3):e0169219. doi: 10.1371/journal.pone.0169219. eCollection 2017.
6
PharmGKB summary: very important pharmacogene information for MT-RNR1.药物基因组知识库总结:MT-RNR1的非常重要的药物基因信息。
Pharmacogenet Genomics. 2016 Dec;26(12):558-567. doi: 10.1097/FPC.0000000000000247.
7
Study of streptomycin-induced ototoxicity: protocol for a longitudinal study.链霉素诱导耳毒性的研究:一项纵向研究方案。
Springerplus. 2016 Jun 17;5(1):758. doi: 10.1186/s40064-016-2429-5. eCollection 2016.
8
Analysis of mitochondrial alterations in Brazilian patients with sensorineural hearing loss using MALDI-TOF mass spectrometry.使用基质辅助激光解吸电离飞行时间质谱法分析巴西感音神经性听力损失患者的线粒体改变。
BMC Med Genet. 2016 May 26;17(1):41. doi: 10.1186/s12881-016-0303-5.
9
Association of nuclear and mitochondrial genes with audiological examinations in Iranian patients with nonaminoglycoside antibiotics-induced hearing loss.伊朗非氨基糖苷类抗生素所致听力损失患者中核基因与线粒体基因与听力学检查的关联
Ther Clin Risk Manag. 2016 Jan 28;12:117-28. doi: 10.2147/TCRM.S90581. eCollection 2016.
10
Sensorineural deafness following routine transurethral resection of the prostate.常规经尿道前列腺切除术后的感音神经性耳聋
BMJ Case Rep. 2015 Nov 12;2015:bcr2015212933. doi: 10.1136/bcr-2015-212933.